Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04585750
Title	The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	PMV Pharmaceuticals, Inc
Indications	Advanced Solid Tumor
Therapies	PC14586 + Pembrolizumab PC14586
Age Groups:	child \| adult \| senior
Covered Countries	USA \| ITA \| GBR \| FRA \| ESP \| DEU \| AUS